5'-Phosphonate modified oligoadenylates as potent activators of human RNase L
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
35078032
DOI
10.1016/j.bmc.2022.116632
PII: S0968-0896(22)00024-4
Knihovny.cz E-zdroje
- Klíčová slova
- 2-5A, OAS-RNase L pathway, Oligoadenylate, Phosphonate oligonucleotide, RNase L,
- MeSH
- adeninnukleotidy chemická syntéza chemie farmakologie MeSH
- endoribonukleasy metabolismus MeSH
- konformace nukleové kyseliny MeSH
- lidé MeSH
- oligoribonukleotidy chemická syntéza chemie farmakologie MeSH
- organofosfonáty chemická syntéza chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 2-5A-dependent ribonuclease MeSH Prohlížeč
- 2',5'-oligoadenylate MeSH Prohlížeč
- adeninnukleotidy MeSH
- endoribonukleasy MeSH
- oligoribonukleotidy MeSH
- organofosfonáty MeSH
The oligoadenylate synthetase-ribonuclease L pathway is a major player in the interferon-induced antiviral defense mechanism of cells. Upon sensing viral dsRNA, 5'-phosphorylated 2',5'-oligoadenylates are synthesized, and subsequently activate latent RNase L. To determine the influence of 5'-phosphate end on the activation of human RNase L, four sets of 5'-phosphonate modified oligoadenylates were prepared on solid-phase. The ability of these 5'-modified oligoadenylates bearing shortened, isosteric and prolonged phosphonate linkages to activate RNase L was explored. We found that isosteric linkages and linkages prolonged by one atom were in general well tolerated by the enzyme with the EC50 values comparable to that of the natural activator. In contrast, linkages shortened by one atom or prolonged by two atoms exhibited decrease in the activity.
Citace poskytuje Crossref.org
